KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren Syndrome: A Retrospective Case–Control Study

OBJECTIVE: Krebs von den Lungen-6 (KL-6) is expressed on regenerating type II pneumocytes and has been recognized as biomarkers in interstitial lung disease (ILD). We aim to identify the role of the serum KL-6 level in patients with newly diagnosed Sjögren syndrome (SS), as well as the correlation b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Yu-Hsiang, Chu, Chen-Chih, Lu, Chun-Chi, Liu, Feng-Cheng, Tang, Shin-En, Chu, Shi-Jye, Kuo, San-Yuan, Chen, Hsiang-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005069/
https://www.ncbi.nlm.nih.gov/pubmed/35422651
http://dx.doi.org/10.2147/JIR.S352085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005069/
https://www.ncbi.nlm.nih.gov/pubmed/35422651
http://dx.doi.org/10.2147/JIR.S352085

Ejemplares similares